St. Jude Children's Research Hospital and the World Health Organization have formed a collaboration, working with partners across the world, and aiming to cure at least 60 percent of children with cancer worldwide by 2030.
FDA has published a draft guidance titled “Master Protocols--Efficient Clinical Trial Design Strategies to Expedite Development of Cancer Drugs and Biologics.”
FDA has approved the supplemental New Drug Application to expand the prescribing information for Kyprolis (carfilzomib) to include a once-weekly dosing option in combination with dexamethasone (once-weekly Kd70) for patients with relapsed or refractory multiple myeloma.
FDA has permitted marketing of ClonoSEQ assay, a next generation sequencing-based test for minimal residual disease in patients with acute lymphoblastic leukemia or multiple myeloma.
FDA has approved Libtayo (cemiplimab-rwlc) for the treatment of patients with metastatic cutaneous squamous cell carcinoma or locally advanced CSCC who are not candidates for curative surgery or curative radiation.
Regular use of aspirin can reduce the risk of developing ovarian cancer and hepatocellular carcinoma, according to two studies published Oct. 4 in JAMA Oncology.
Genentech announced the results for its investigational medicine entrectinib, from an integrated analysis of the pivotal phase II STARTRK-2, phase I STARTRK-1, and phase I ALKA trials, which showed that entrectinib shrank tumors (objective response rate) in 77.4 percent of people with locally advanced or metastatic ROS1-positive non-small cell lung cancer.
In the spring of 2001, I visited a longtime friend and collaborator, Alexandre Barbault, to share with him my vision of using low levels radiofrequency electromagnetic fields for the treatment of cancer.
Ruth O'Regan was named chief scientific officer of the Big Ten Cancer Research Consortium.
Peter Wiklund, a surgeon who pioneered robot-assisted cystectomy, has been appointed director of the Bladder Cancer Program at the Mount Sinai Health System and professor of urology in the Department of Urology at the Icahn School of Medicine at Mount Sinai.
